News Results (top 2,000 results)
|
Select a resource
Filter by
Sort by
|
News Article
January 4, 2012
Melanoma risk was 60 percent higher among those not taking antiestrogen therapy. Researcher cautions against widespread antiestrogen supplementation use. Study included 7,360 women with breast cancer.
Read more
News Article
May 15, 2012
Pre-birth exposure to the anti-HIV drug tenofovir does not adversely affect pregnancy outcomes and does not increase birth defects, growth abnormalities, or kidney problems in infants born to African women who are HIV positive, supporting the use of this drug during pregnancy, according to a study by a team of international researchers published in this week's PLoS Medicine.
Read more
News Article
May 1, 2012
Infants born to women who used the anti-HIV drug tenofovir as part of an anti-HIV drug regimen during pregnancy do not weigh less at birth and are not of shorter length than infants born to women who used anti-HIV drug regimens that do not include tenofovir during pregnancy, according to findings from a National Institutes of Health network study. However, at 1 year of age, children born to the tenofovir-treated mothers were slightly shorter and had slightly smaller head circumference.
Read more
News Article
January 20, 2012
Shortages of key drugs used to fight infections represent a public health emergency and can put patients at risk, according to a review published in Clinical Infectious Diseases and available online. Frequent anti-infective shortages can substantially alter clinical care and may lead to worse outcomes for patients, particularly as the development of new anti-infectives has slowed and the prevalence of multidrug-resistant pathogens is increasing.
Read more
News Article
May 23, 2012
A novel anti-inflammatory drug could help to improve survival in the most severe cases of malaria by preventing the immune system from causing irrevocable brain and tissue damage.
Walter and Eliza Hall Institute researchers have shown that a new class of anti-inflammatory agents, called IDR (innate defense regulator) peptides, could help to increase survival from severe clinical malaria when used in combination with antimalarial drugs.
Read more
News Article
January 17, 2012
In future it should be possible to produce the best anti-malaria drug, artemisinin, more economically and in sufficient volumes for all patients.
Read more
News Article
November 8, 2024
A special particle trap designed to fit in a truck let researchers haul 70 protons across the CERN campus. Antiprotons may be next.
Read more
News Article
September 27, 2023
In a first, scientists dropped antihydrogen atoms and measured how they fell.
Read more
News Article
March 7, 2012
An international effort at CERN, led by a Canadian team of researchers, has used microwaves to manipulate antihydrogen atoms, providing the first glimpse of an "anti-atomic fingerprint." The present measurement involved confining anti-atoms in a magnetic trap and irradiating them with microwaves. Precise tuning of the microwave frequency and magnetic field enabled researchers to hit an internal resonance, kicking atoms out of the trap, and revealing information about their properties.
Read more
News Article
March 26, 2012
A new catheter coating that reduces bacterial attachment to its surface is being developed by scientists who are reporting their work at the Society for General Microbiology's Spring Conference in Dublin this week. The antimicrobial coating could eventually be applied to other medical implants to reduce infection which would provide significant socioeconomic benefits to the NHS.
Read more
|






